Search

everythinglearnresearchcommunity

for

Search:↓

Four natural compounds were found to promote hair growth effectively.

Topical tofacitinib helped a man with severe scalp condition after other treatments failed.

Pediatric dermatologists have varied preferences for treating alopecia areata in children, with no standard FDA-approved treatments and some using JAK inhibitors despite risks.

Patients with alopecia areata face challenges accessing Janus kinase inhibitors, but some see positive results.

Intravenous methylprednisolone helped over half of alopecia areata patients regrow hair, but many relapsed.

No single ideal JAK inhibitor for alopecia areata has been determined; JAK3 inhibitors may be promising with fewer side effects.

New treatments for sudden hair loss include oral medications and a special laser, both showing promise in hair regrowth.

IL-15 promotes hair growth and protects hair follicles.

JAK inhibitors do not improve hair regrowth in androgenic alopecia but may prevent further hair loss.

Combining oral minoxidil with JAK inhibitors helps regrow hair in severe alopecia areata cases.

The study concluded that immune cells attacking hair follicles cause hair loss in alopecia, with genetics and environment also playing a role, and highlighted the potential of certain treatments.

Antihelminthic drugs treat worm infections but face challenges like low treatment coverage and potential drug resistance, with various side effects reported for different drugs.

The Polish Society of Dermatology recommends treatments for alopecia areata that vary by severity, including topical and systemic medications, with long-term maintenance important for management.

Baricitinib is a new, effective treatment for advanced alopecia areata but is costly and has risks.

Ayurvedic treatment, including leech therapy, can effectively regrow hair in alopecia areata.

The niche environment controls stem cell behavior and plasticity, which is important for tissue health and repair.

The research suggests that a specific skin gene can be controlled by signals within and between cells and is wrongly activated in certain skin diseases.

Leflunomide successfully treated a rare skin condition in a liver transplant patient.

Ultra-high molecular weight poly-γ-glutamic acid may help promote hair growth.

Deleting Snai2 and Snai3 causes fatal autoimmunity.

Inflammation in psoriasis may trigger antimicrobial peptides and cell death.

Plant-based chemicals may help hair growth and prevent hair loss but need more research to compete with current treatments.

Certain miRNAs might be involved in a hair loss condition called frontal fibrosing alopecia and could possibly help in its diagnosis.

Double-stranded RNA activates a pathway that causes a skin protein to be expressed in the wrong place.

Poly-γ-glutamic acid may help reduce hair loss.

Lgr5 is a marker for active, long-lasting stem cells in mouse hair follicles.

Overexpressing the mineralocorticoid receptor in mouse skin causes skin thinning, early skin barrier development, eye issues, and hair loss.

The mineralocorticoid receptor may play a role in skin and hair health and could be a new target for treating related disorders.

Polycystic ovary syndrome (PCOS) was first described in 1721, officially diagnosed in the 1990s, and is now known to be partly genetic and linked to insulin resistance, with increased risk of cardiovascular disease and carbohydrate metabolism issues.

The combined Myo-inositol and D-chiro-inositol treatment improved weight, hormone levels, and skin conditions in women with PCOS.